Post dialysis osmotic demyelination syndrome: a case report
DOI:
https://doi.org/10.18203/2320-6012.ijrms20252421Keywords:
Osmotic demyelination, Hyponatremia, Post dialysisAbstract
Osmotic demyelination syndrome (ODS) is a serious, irreversible, highly lethal clinical condition that is rarely described in the literature. It is caused by rapid correction of serum sodium, which generates abrupt changes in cerebrospinal fluid osmolarity, triggering neurological signs typical of this condition. It can occur due to rapid sodium correction through intravenous fluids and after emergent dialysis treatment in patients with renal pathologies, as described in this case; therefore, we consider it important to emphasize that dialysis treatment should be individualized based on a strict assessment of the internal environment for its correct correction, thus avoiding long-term sequelae and even death. We present a 38-year-old male patient with stage 5 chronic kidney disease, which did not allow dialysis treatment, admitted to a second-level hospital due to uremic encephalopathy and severe hyponatremia. During his stay in intensive care, he developed tonic-clonic seizures and neurological impairment, which began after emergency dialysis treatment, where rapid correction of trans dialytic serum sodium values was performed, generating classic neurological signs and imaging studies compatible with ODS.
Metrics
References
Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D, et al. Hyponatraemia diagnosis and treatment clinical practice guidelines. Nefrologia: publicacion oficial de la Sociedad Espanola Nefrologia. 2017;37(4):370-80. DOI: https://doi.org/10.1016/j.nefro.2017.03.021
Bastos AP, Rocha PN. Osmotic demyelination as a complication of hyponatremia correction: a systematic review. J Bras Nefrol. 2024;46(1):47-55. DOI: https://doi.org/10.1590/2175-8239-jbn-2022-0114pt
Yessayan LT, Szamosfalvi B, Rosner MH. Management of dysnatremias with continuous renal replacement therapy. Semin Dial. 2021;34(6):472-9. DOI: https://doi.org/10.1111/sdi.12983
Huang, WY, Weng, WC, Peng, TI, Ro, LS, Yang, CW y Chen, KH. Mielinolisis pontina central y extrapontina después de la corrección rápida de la hiponatremia mediante hemodiálisis en un paciente urémico. Renal Failure. 2007;29(5):635–8. DOI: https://doi.org/10.1080/08860220701392314
Wendland EM, Kaplan AA. A proposed approach to the dialysis prescription in severely hyponatremic patients with end-stage renal disease. Semin Dial. 2012;25(1):82-5. DOI: https://doi.org/10.1111/j.1525-139X.2011.00981.x
Tarhan NC, Agildere AM, Benli US, Ozdemir FN, Aytekin C, Can U. Osmotic demyelination syndrome in end-stage renal disease after recent hemodialysis: MRI of the brain. Am J Roentgenol. 2004;182(3):809-16.
Tarhan NC, Agildere AM, Benli US, Ozdemir FN, Aytekin C, Can U. Osmotic demyelination syndrome in end-stage renal disease after recent hemodialysis: MRI of the brain. Am J Roentgenol. 2004;182(3):809-16. DOI: https://doi.org/10.2214/ajr.182.3.1820809
Pattanashetti N, Bharati J, Kohli HS, Gupta KL, Ramachandran R. Successful management of severe hyponatremia in CKD‐VD: In a cost limited setting. Hemodialysis International. 2019;23(2):69-71. DOI: https://doi.org/10.1111/hdi.12716
Dhrolia MF, Akhtar SF, Ahmed E, Naqvi A, Rizvi A. Azotemia protects the brain from osmotic demyelination on rapid correction of hyponatremia. Saudi J Kid DisTransp. 2014;25(3):558-66.
Dhrolia MF, Akhtar SF, Ahmed E, Naqvi A, Rizvi A. Azotemia protects the brain from osmotic demyelination on rapid correction of hyponatremia. Saudi J Kid Dis Transpl. 2014;25(3):558-66. DOI: https://doi.org/10.4103/1319-2442.132183